Revisiting the promise and pitfalls of mitochondrial replacement therapies
Human Reproduction · 2026
DOI: 10.1093/humrep/deag020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, 2026. Verfasst von Nuno Costa-Borges und 1 weiteren Autor:innen. Beteiligte Einrichtung: Embryotools SL, Science Park of Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: DNA, Mitochondrial, Mitochondrial Diseases, Mitochondrial Replacement Therapy, Nuclear Transfer Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Abstract (Originalsprache)
Mitochondrial replacement therapies (MRTs) have been proposed as a means of avoiding the transmission of pathogenic mitochondrial DNA (mtDNA) mutations from mother to child. While clinical cases using this groundbreaking strategy have now been reported for the two principal MRT methods—pronuclear transfer and maternal spindle transfer—recent data continues to raise questions about the reliability of these approaches for disease prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Embryotools SL, Science Park of Barcelona, Barcelona, Spain.
- Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
- Juno Genetics, Oxford, UK.
ORCID-Profile: Nuno Costa-Borges, Dagan Wells
Zitieren
APA
Costa-Borges, N., & Wells, D. (2026). Revisiting the promise and pitfalls of mitochondrial replacement therapies. Human Reproduction. https://doi.org/10.1093/humrep/deag020
Vancouver
Costa-Borges N, Wells D. Revisiting the promise and pitfalls of mitochondrial replacement therapies. Human Reproduction. 2026. doi:10.1093/humrep/deag020
BibTeX
@article{CostaBorges2026,
author = {Costa-Borges, Nuno and Wells, Dagan},
title = {Revisiting the promise and pitfalls of mitochondrial replacement therapies},
journal = {Human Reproduction},
year = {2026},
doi = {10.1093/humrep/deag020}
}
EUVIMED